COMPUTED DESCRIPTORS
| Molecular Weight | 285.30 g/mol |
|---|---|
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 285.13404868 g/mol |
| Monoisotopic Mass | 285.13404868 g/mol |
| Topological Polar Surface Area | 20.3 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 329 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Lanperisone is a 2-methyl-3-(pyrrolidin-1-yl)-1-[4-(trifluoromethyl)phenyl]propan-1-one in which the methyl group at position 2 adopts R-configuration. It is a muscle relaxant and induces ferroptosis in cancer cells. It has a role as a muscle relaxant, a ferroptosis inducer, an antineoplastic agent, a voltage-gated sodium channel blocker and a calcium channel blocker. It is a conjugate base of a lanperisone(1+).